Wikidata

(Q37832316)

English

An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development

scientific article published on 23 January 2011

In more languages

Statements

title
An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21266202
retrieved
24 August 2017
publication date
23 January 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21266202
retrieved
24 August 2017
page(s)
324-332
1 reference
stated in
Europe PubMed Central
PubMed ID
21266202
retrieved
24 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q37832316&oldid=2155630081"